insights_auto
Why is BOT down 7.69%?
Dive Deeperchevron_right
BOT:ASX
Botanix Pharmaceuticals Ltd
A$0.012
arrow_downward
-7.69%(-0.0010) 1D
Oct 19, 4:13:35 PM GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BOT...
Open
A$0.01
High
A$0.01
Low
A$0.01
Mkt. cap
43.08M
Avg. vol.
7.36M
Volume
19.69M
52-wk high
A$0.17
52-wk low
A$0.01
EPS
-A$0.03
Shares outstanding
2.76B
No. of employees
11
Open
A$0.01
High
A$0.01
Low
A$0.01
Mkt. cap
43.08M
Avg. vol.
7.36M
Volume
19.69M
52-wk high
A$0.17
52-wk low
A$0.01
EPS
-A$0.03
Shares outstanding
2.76B
No. of employees
11
News stories
From web sources and news partners
TradingView
·
31 minutes ago
Midday Pulse: S&P 500 top intraday losers
bloomingbit
·
1 hour ago
U.S. Stocks Turn Higher; Nasdaq Up 1.36%
Investor's Business Daily
·
33 minutes ago
Magnificent Seven Are Losing Their Earnings Luster
24/7 Wall St.
·
2 hours ago
S&P 500 Climbs to 7,721 at Midday, Led by a Tech-Heavy Surge
Profile
Botanix Pharmaceuticals is listed on the Australian Securities Exchange with the issue code BOT. The Company is headquartered in Perth, Western Australia and Philadelphia, USA. It is a clinical stage synthetic cannabinoid company, focusing on the compound Cannabidiol. The company's lead product is Sofdra, which treats axillary hyperhidrosis. The company has two separate development platforms, dermatology and antimicrobial. Botanix also has an exclusive license to use a proprietary drug delivery system Permetrex, for direct skin delivery of active pharmaceuticals which is utilised in all of their programs. Wikipedia
About Botanix Pharmaceuticals Ltd